Nature Communications (Apr 2022)

ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer

  • Shaghayegh Nouruzi,
  • Dwaipayan Ganguli,
  • Nakisa Tabrizian,
  • Maxim Kobelev,
  • Olena Sivak,
  • Takeshi Namekawa,
  • Daksh Thaper,
  • Sylvan C. Baca,
  • Matthew L. Freedman,
  • Adeleke Aguda,
  • Alastair Davies,
  • Amina Zoubeidi

DOI
https://doi.org/10.1038/s41467-022-29963-5
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 15

Abstract

Read online

Following androgen receptor pathway inhibition prostate cancers can differentiate towards the neuroendocrine lineage. Here, the authors identify epigenetic alterations regulated by ASCL1 and suggest targeting ASCL1 to reverse the neuroendocrine phenotype.